Nikon contributed to a $270m round valuing the DNA sequencing eqiupment producer at $3.4bn as it prepares to pursue a public listing.
Oxford Nanopore, a UK-based DNA sequencing technology spinout of University of Oxford, secured £195m ($270m) in equity financing today from investors including imaging technology producer Nikon. IP Group, Temasek, Wellington Management and M&G Investment also took part in the round, alongside unnamed existing backers, at a valuation of $3.4bn. Founded in 2005, Oxford Nanopore has…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.